Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.64
Delayed Data
As of 4:00pm ET
 -0.05 / -1.07%
Today’s Change
3.42
Today|||52-Week Range
6.37
-8.84%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 10.25, with a high estimate of 14.00 and a low estimate of 6.50. The median estimate represents a +120.91% increase from the last price of 4.64.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.36
Sales
$5.2M
Reporting Date
Mar 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -63.64%
 
 
 
 
 
 
Growthannually -22.99%
 
 
 
 
 
 

Sales

Growthquarterly -7.71%
 
 
 
 
 
 
Growthannually 63.68%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.